Literature DB >> 3501349

Oestrogen induced suppression of collagen arthritis: I. Long term oestradiol treatment of DBA/1 mice reduces severity and incidence of arthritis and decreases the anti type II collagen immune response.

R Holmdahl1, L Jansson, B Meyerson, L Klareskog.   

Abstract

Experimental animal models can be used to help understand how oestrogen modulates autoimmune arthritis. We have previously shown that castration of female DBA/1 mice exaggerates arthritis induced with type II collagen. This report shows that treatment of castrated DBA/1 mice with low doses (0.2 micrograms twice a week) of beta-oestradiol reduces the incidence (37% vs 78% in controls) and severity (3.9 vs 5.6 mean scores) of arthritis. Levels of IgG anti type II collagen antibodies are decreased whereas levels of IgM antibodies are increased in the beta-oestradiol treated mice. The T cell response, as measured by a 3H-thymidine assay, is reduced in the beta-oestradiol treated mice. The results suggest that treatment with low doses of beta-oestradiol exerts a suppressive effect on both development of collagen arthritis as well as T cell dependent immune reactivity towards type II collagen.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3501349      PMCID: PMC1542083     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

1.  ESTROGEN PHARMACOLOGY. II. SUPPRESSION OF EXPERIMENTAL IMMUNE POLYARTHRITIS.

Authors:  M N MUELLER; A KAPPAS
Journal:  Proc Soc Exp Biol Med       Date:  1964-12

2.  Structural studies on cartilage collagen employing limited cleavage and solubilization with pepsin.

Authors:  E J Miller
Journal:  Biochemistry       Date:  1972-12-19       Impact factor: 3.162

3.  Interactions between the gonadal steroids and the immune system.

Authors:  C J Grossman
Journal:  Science       Date:  1985-01-18       Impact factor: 47.728

4.  Approach to the study of the role of sex hormones in autoimmunity.

Authors:  A D Steinberg; K A Melez; E S Raveche; J P Reeves; W A Boegel; P A Smathers; J D Taurog; L Weinlein; M Duvic
Journal:  Arthritis Rheum       Date:  1979-11

5.  Oral contraceptives and rheumatoid arthritis: further evidence for a preventive effect.

Authors:  J P Vandenbroucke; H A Valkenburg; J W Boersma; A Cats; J J Festen; O Huber-Bruning; J J Rasker
Journal:  Lancet       Date:  1982-10-16       Impact factor: 79.321

6.  Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus.

Authors:  P Jungers; M Dougados; C Pélissier; F Kuttenn; F Tron; P Lesavre; J F Bach
Journal:  Arthritis Rheum       Date:  1982-06

7.  T lymphocytes in collagen II-induced arthritis in mice. Characterization of arthritogenic collagen II-specific T-cell lines and clones.

Authors:  R Holmdahl; L Klareskog; K Rubin; E Larsson; H Wigzell
Journal:  Scand J Immunol       Date:  1985-09       Impact factor: 3.487

8.  Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice.

Authors:  J M Stuart; A S Townes; A H Kang
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

9.  Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice.

Authors:  J R Roubinian; N Talal; J S Greenspan; J R Goodman; P K Siiteri
Journal:  J Exp Med       Date:  1978-06-01       Impact factor: 14.307

10.  Serum transfer of collagen-induced arthritis in mice.

Authors:  J M Stuart; F J Dixon
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

View more
  23 in total

Review 1.  Oestrogens, joint disease, and cartilage.

Authors:  C L Chander; T D Spector
Journal:  Ann Rheum Dis       Date:  1991-03       Impact factor: 19.103

2.  Maintained pregnancy levels of oestrogen afford complete protection from post-partum exacerbation of collagen-induced arthritis.

Authors:  R Mattsson; A Mattsson; R Holmdahl; A Whyte; G A Rook
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

3.  Oestrogen exhibits type II collagen protective effects and attenuates collagen-induced arthritis in rats.

Authors:  R H Nielsen; C Christiansen; M Stolina; M A Karsdal
Journal:  Clin Exp Immunol       Date:  2008-01-28       Impact factor: 4.330

Review 4.  What can we learn about rheumatoid arthritis from animal models?

Authors:  L Klareskog
Journal:  Springer Semin Immunopathol       Date:  1989

5.  Estren-mediated inhibition of T lymphopoiesis is estrogen receptor-independent whereas its suppression of T cell-mediated inflammation is estrogen receptor-dependent.

Authors:  U Islander; M C Erlandsson; T Chavoshi; C Jochems; S Movérare; S Nilsson; C Ohlsson; J-A Gustafsson; H Carlsten
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

6.  Estriol Reduces Pulmonary Immune Cell Recruitment and Inflammation to Protect Female Mice From Severe Influenza.

Authors:  Meghan S Vermillion; Rebecca L Ursin; Sarah E Attreed; Sabra L Klein
Journal:  Endocrinology       Date:  2018-09-01       Impact factor: 4.736

7.  A study on type II collagen-induced arthritis in allogeneic bone marrow chimaeras.

Authors:  M Fujita; M Mishima; K Iwabuchi; C Katsume; T Gotohda; K Ogasawara; Y Mizuno; R A Good; K Onoé
Journal:  Immunology       Date:  1989-03       Impact factor: 7.397

8.  In vivo modulation of murine serum tumour necrosis factor and interleukin-6 levels during endotoxemia by oestrogen agonists and antagonists.

Authors:  S H Zuckerman; N Bryan-Poole; G F Evans; L Short; A L Glasebrook
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

9.  Additive effects of suboptimal doses of estrogen and cortisone on the suppression of T lymphocyte dependent inflammatory responses in mice.

Authors:  H Carlsten; M Verdrengh; M Taube
Journal:  Inflamm Res       Date:  1996-01       Impact factor: 4.575

10.  17beta-Estradiol utilizes the estrogen receptor to regulate CD16 expression in monocytes.

Authors:  P R Kramer; V Winger; S F Kramer
Journal:  Mol Cell Endocrinol       Date:  2007-09-04       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.